GlaxoSmithKline Secures Human Genome Sciences Takeover with Sweetened Offer
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 7 (Table of Contents)
Published: 20 Jul-2012
DOI: 10.3833/pdr.v2012.i7.1782 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
After a 3-month pursuit, GlaxoSmithKline (GSK) has negotiated a deal on friendly terms to acquire its long-time partner Human Genome Sciences (HGS) for approximately US$3 B net of cash and debt...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS